查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1971252

生物銀行市場分析及預測（至2035年）：依類型、產品、服務、技術、應用、材料類型、最終使用者、流程、設備及解決方案分類

Biobanking Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Application, Material Type, End User, Process, Equipment, Solutions
出版日期: | 出版商: Global Insight Services | 英文 316 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

生物銀行市場預計將從2024年的834億美元成長到2034年的1,825億美元，複合年成長率約為8.3%。生物銀行市場涵蓋用於研發和治療目的的生物樣本的收集、處理、儲存和分發。它支持基因組學、個人化醫療和藥物研發的進步。該市場的成長動力來自於儲存解決方案、資料管理和法規遵循的技術創新。對精準醫療和慢性病研究日益成長的需求正在推動市場成長，而生物樣本庫在促進獲取高品質、符合倫理規範的生物樣本方面發揮著至關重要的作用。

生物銀行市場正經歷顯著擴張，主要驅動力來自對個人化醫療日益成長的需求以及基因組學的進步。從細分市場來看，設備領域佔據主導，耗材和軟體解決方案對於高效的生物銀行運作至關重要。諸如儲存容器和試劑等耗材是樣本保存的必需品，而軟體解決方案則增強了資料管理和可追溯性。服務領域的成長率排名第二，樣本保存服務對於生物材料的長期儲存至關重要。此外，用於再生醫學和治療應用的生物樣本庫的快速成長也值得關注。生物銀行流程的自動化數位化正在加速推進，從而提高營運效率和數據準確性。對冷凍保存技術和生物標記發現的投資預計將進一步推動市場發展。對倫理和監管合規性的日益重視確保了資料的完整性和提供者的保密性。這種不斷變化的環境為創新和策略夥伴關係提供了有利機會。

市場區隔
按類型 以人群為基礎的生物樣本庫、以疾病為導向的生物樣本庫、組織生物樣本庫、臍帶生物樣本庫、幹細胞生物樣本庫
產品 設備、耗材、軟體、分析儀器、儲存系統
服務 檢體採集、檢體處理、檢體分析、檢體儲存、檢體運輸
科技 自動化生物銀行、虛擬生物銀行、人工智慧、冷凍保存、基因組學
目的 治療、研究、臨床試驗、藥物發現、個人化醫療
材料類型 血液製品、人體組織、核酸、細胞株、生物體液
最終用戶 學術機構、製藥公司、醫院、研究機構、診斷中心
過程 收集、保存、分發、品管、資料管理
裝置 冷藏庫、冷凍庫、自動化儲存系統、機器人運輸系統、離心分離器
解決方案 生物銀行軟體、資料管理解決方案、樣本追蹤解決方案、庫存管理、合規解決方案

市場概況：

隨著主要企業推出創新產品以抓住新機遇，生物銀行市場正經歷市場佔有率的動態變化。定價策略經過精心製定，旨在平衡競爭定位和附加價值。對個人化和再生醫學的關注正在推動新產品的發布，並促進市場發展。北美繼續引領市場，其次是歐洲和亞太地區。每個地區都在根據當地需求和技術進步進行調整。由於新參與企業和現有企業的整合，生物銀行領域的競爭日益激烈。法規結構，尤其是在北美和歐洲，對於塑造營運標準和影響市場動態至關重要。像賽默飛世爾科技和凱傑這樣的公司因其創新方法和對嚴格法規的遵守而成為行業標竿。該市場的特點是自動化數位化方面的大量投資，提高了樣本儲存和搜尋的效率。監管環境的持續變化既給市場參與企業帶來了挑戰，也帶來了機會。

主要趨勢和促進因素：

生物銀行市場正經歷強勁成長，這主要得益於個人化醫療和基因組學研究的進步。關鍵趨勢包括將人工智慧 (AI) 和機器學習技術應用於數據分析和樣本管理，從而提升效率和準確性，最終改善研究成果。另一個重要趨勢是生物樣本庫與製藥公司之間合作的加強。這種夥伴關係對於藥物發現和開發至關重要，因為取得多樣化的生物樣本能夠加速研究方​​法的發展。為確保倫理標準和資料隱私，法規結構也不斷完善，從而增強了相關人員之間的信任。此外，慢性病盛行率的上升和人口老化也推動了對生物銀行服務的需求。隨著醫療保健系統日益重視預防醫學，生物樣本庫在理解疾病機制和開發標靶治療發揮著至關重要的作用。新興市場正在進行大量投資，為企業拓展業務和創新創造了機會。能夠提供可擴展解決方案並符合監管標準的公司，將在這個充滿活力的環境中佔據有利地位。

壓制與挑戰：

生物銀行市場面臨許多重大限制與挑戰。首先，嚴格的法規結構和倫理考量構成了阻礙。這些法規因司法管轄區而異，增加了合規難度並提高了營運成本。其次，由於生物樣本長期儲存和維護高成本，生物樣本庫面臨巨大的財務壓力。此外，確保長期儲存樣本的品質和完整性也存在技術挑戰。這需要持續投資於最先進的保存技術。另外，缺乏標準化的通訊協定檢體和處理流程導致檢體品質有差異，進而影響研究結果。此外，資料管理和互通性也面臨挑戰。生物樣本庫會產生大量數據，需要複雜的系統進行儲存和分析。最後，人們對資料隱私和安全的日益關注意味著資料外洩可能會損害公眾信任，並阻礙人們參與生物銀行業務。所有這些因素共同阻礙了市場擴張和有效運作。

目錄

第1章：執行摘要

第2章 市場亮點

第3章 市場動態

  • 宏觀經濟分析
  • 市場趨勢
  • 市場促進因素
  • 市場機遇
  • 市場限制因素
  • 複合年均成長率：成長分析
  • 影響分析
  • 新興市場
  • 技術藍圖
  • 戰略框架

第4章：細分市場分析

  • 市場規模及預測：依類型
    • 基於人群的生物樣本庫
    • 疾病導向生物樣本庫
    • 組織生物庫
    • 臍帶血生物庫
    • 幹細胞生物庫
  • 市場規模及預測：依產品分類
    • 裝置
    • 消耗品
    • 軟體
    • 裝置
    • 儲存系統
  • 市場規模及預測：依服務分類
    • 檢體採集
    • 檢體處理
    • 檢體分析
    • 檢體儲存
    • 檢體運輸
  • 市場規模及預測：依技術分類
    • 自動化生物銀行
    • 虛擬生物銀行
    • 人工智慧
    • 冷凍保存
    • 基因組學
  • 市場規模及預測：依應用領域分類
    • 治療藥物
    • 研究
    • 臨床試驗
    • 藥物發現
    • 個人化醫療
  • 市場規模及預測：依材料類型分類
    • 血液製品
    • 人體組織
    • 核酸
    • 細胞株
    • 生物液體
  • 市場規模及預測：依最終用戶分類
    • 學術機構
    • 製藥公司
    • 醫院
    • 研究所
    • 診斷中心
  • 市場規模及預測：依製程分類
    • 收藏
    • 保持
    • 分配
    • 品管
    • 資料管理
  • 市場規模及預測：依設備類型分類
    • 冷藏庫
    • 冷凍庫
    • 自動化儲存系統
    • 機器人搬運系統
    • 離心機
  • 市場規模及預測：按解決方案分類
    • 生物銀行軟體
    • 資料管理解決方案
    • 檢體追蹤解決方案
    • 庫存管理
    • 合規解決方案

第5章 區域分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲
  • 亞太地區
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲
    • 台灣
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他歐洲國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 撒哈拉以南非洲
    • 其他中東和非洲地區

第6章 市場策略

  • 供需差距分析
  • 貿易和物流限制
  • 價格、成本和利潤率趨勢
  • 市場滲透率
  • 消費者分析
  • 監管概述

第7章 競爭訊息

  • 市場定位
  • 市場占有率
  • 競爭基準
  • 主要企業的策略

第8章：公司簡介

  • BioCision
  • Brooks Life Sciences
  • Biostorage Technologies
  • Cryoport
  • Tecan Group
  • BioKryo
  • Hamilton Company
  • BioLife Solutions
  • DNA Genotek
  • Indivumed
  • Provia Laboratories
  • RUCDR Infinite Biologics
  • Zyagen
  • GenVault
  • Cureline

第9章 關於我們

簡介目錄
Product Code: GIS33673

Biobanking Market is anticipated to expand from $83.4 billion in 2024 to $182.5 billion by 2034, growing at a CAGR of approximately 8.3%. The Biobanking Market encompasses the collection, processing, storage, and distribution of biological samples for research and therapeutic purposes. It supports advancements in genomics, personalized medicine, and drug development. This market is driven by technological innovations in storage solutions, data management, and regulatory compliance. Increasing demand for precision medicine and chronic disease research is propelling growth, with biobanks playing a pivotal role in facilitating access to high-quality, ethically sourced biospecimens.

The Biobanking Market is experiencing significant expansion, primarily driven by heightened demand for personalized medicine and advancements in genomics. Among the segments, the equipment sector is leading, with consumables and software solutions being pivotal for efficient biobanking operations. Consumables such as storage containers and reagents are essential for sample preservation, while software solutions enhance data management and traceability. The service segment is the second highest performing, with sample storage services being crucial for long-term biological material preservation. Additionally, the rapid growth of biobanks focused on regenerative medicine and therapeutic applications is noteworthy. Automation and digitalization of biobanking processes are gaining momentum, improving operational efficiency and data accuracy. Investments in cryopreservation and biomarker discovery are expected to further propel the market. The emphasis on ethical and regulatory compliance is increasing, ensuring data integrity and donor confidentiality. This evolving landscape presents lucrative opportunities for innovation and strategic partnerships.

Market Segmentation
TypePopulation-based Biobanks, Disease-oriented Biobanks, Tissue Biobanks, Umbilical Cord Biobanks, Stem Cell Biobanks
ProductEquipment, Consumables, Software, Instruments, Storage Systems
ServicesSample Collection, Sample Processing, Sample Analysis, Sample Storage, Sample Transportation
TechnologyAutomated Biobanking, Virtual Biobanking, Artificial Intelligence, Cryopreservation, Genomics
ApplicationTherapeutics, Research, Clinical Trials, Drug Discovery, Personalized Medicine
Material TypeBlood Products, Human Tissues, Nucleic Acids, Cell Lines, Biological Fluids
End UserAcademic Institutions, Pharmaceutical Companies, Hospitals, Research Laboratories, Diagnostic Centers
ProcessCollection, Preservation, Distribution, Quality Control, Data Management
EquipmentRefrigerators, Freezers, Automated Storage Systems, Robotic Handling Systems, Centrifuges
SolutionsBiobanking Software, Data Management Solutions, Sample Tracking Solutions, Inventory Management, Compliance Solutions

Market Snapshot:

The biobanking market is witnessing a dynamic shift in market share, with leading companies launching innovative products to capture emerging opportunities. Pricing strategies are being meticulously crafted, balancing between competitive positioning and value addition. The focus on personalized medicine and regenerative therapies has catalyzed new product launches, driving the market's evolution. North America remains at the forefront, with Europe and Asia-Pacific trailing closely, each adapting to regional demands and technological advancements. Competition within the biobanking sector is intensifying, driven by the entrance of new players and the consolidation of existing ones. Regulatory frameworks, particularly in North America and Europe, are crucial in shaping operational standards, impacting market dynamics. Companies like Thermo Fisher Scientific and Qiagen are benchmarked for their innovative approaches and compliance with stringent regulations. The market is characterized by significant investments in automation and digitalization, enhancing sample storage and retrieval efficiencies. The continuous evolution of regulatory landscapes offers both challenges and opportunities for market participants.

Geographical Overview:

The biobanking market is witnessing notable growth across various regions, each characterized by unique dynamics. North America leads the market, driven by substantial investments in life sciences and personalized medicine. The region's robust healthcare infrastructure and research initiatives further bolster its position. Europe follows, with a strong focus on biobanking for regenerative medicine and rare disease research. The region's regulatory framework supports innovation and collaboration. In Asia Pacific, the market is expanding rapidly, fueled by advancements in biotechnology and government support for healthcare research. Countries like China and India are emerging as key players, investing heavily in biobanking infrastructure. Latin America and the Middle East & Africa are also exhibiting growth potential. In Latin America, increasing research activities and collaborations are driving demand. Meanwhile, the Middle East & Africa are recognizing biobanking's role in enhancing healthcare outcomes and fostering economic development through innovation.

Key Trends and Drivers:

The biobanking market is experiencing robust growth, driven by advancements in personalized medicine and genomic research. Key trends include the integration of artificial intelligence and machine learning to enhance data analysis and sample management. These technologies facilitate more efficient and accurate processing, leading to improved research outcomes. Another significant trend is the increasing collaboration between biobanks and pharmaceutical companies. This partnership is crucial for drug discovery and development, as access to diverse biological samples accelerates the research process. Regulatory frameworks are also evolving to ensure ethical standards and data privacy, fostering trust among stakeholders. Furthermore, the rise in chronic diseases and the aging population are driving demand for biobanking services. As healthcare systems focus on preventive care, biobanks play a pivotal role in understanding disease mechanisms and developing targeted therapies. Emerging markets are witnessing substantial investments, presenting opportunities for expansion and innovation. Companies that can offer scalable solutions and adhere to regulatory standards are well-positioned to thrive in this dynamic landscape.

Restraints and Challenges:

The biobanking market is encountering several significant restraints and challenges. Firstly, stringent regulatory frameworks and ethical considerations impose barriers. These regulations vary across jurisdictions, complicating compliance and increasing operational costs. Secondly, biobanks face substantial financial constraints due to the high costs associated with long-term storage and maintenance of biological samples. Moreover, there is a technological challenge in ensuring the quality and integrity of stored samples over extended periods. This requires continuous investment in state-of-the-art preservation technologies. Additionally, the lack of standardized protocols for sample collection and processing leads to variability in sample quality, impacting research outcomes. Furthermore, there is a challenge in data management and interoperability. Biobanks generate vast amounts of data that require sophisticated systems for storage and analysis. Lastly, there is a growing concern about data privacy and security, as breaches can undermine public trust and hinder participation in biobanking initiatives. These factors collectively impede the market's expansion and effectiveness.

Key Players:

BioCision, Brooks Life Sciences, Biostorage Technologies, Cryoport, Tecan Group, BioKryo, Hamilton Company, BioLife Solutions, DNA Genotek, Indivumed, Provia Laboratories, RUCDR Infinite Biologics, Zyagen, GenVault, Cureline

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Application
  • 2.6 Key Market Highlights by Material Type
  • 2.7 Key Market Highlights by End User
  • 2.8 Key Market Highlights by Process
  • 2.9 Key Market Highlights by Equipment
  • 2.10 Key Market Highlights by Solutions

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Population-based Biobanks
    • 4.1.2 Disease-oriented Biobanks
    • 4.1.3 Tissue Biobanks
    • 4.1.4 Umbilical Cord Biobanks
    • 4.1.5 Stem Cell Biobanks
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Equipment
    • 4.2.2 Consumables
    • 4.2.3 Software
    • 4.2.4 Instruments
    • 4.2.5 Storage Systems
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Sample Collection
    • 4.3.2 Sample Processing
    • 4.3.3 Sample Analysis
    • 4.3.4 Sample Storage
    • 4.3.5 Sample Transportation
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Automated Biobanking
    • 4.4.2 Virtual Biobanking
    • 4.4.3 Artificial Intelligence
    • 4.4.4 Cryopreservation
    • 4.4.5 Genomics
  • 4.5 Market Size & Forecast by Application (2020-2035)
    • 4.5.1 Therapeutics
    • 4.5.2 Research
    • 4.5.3 Clinical Trials
    • 4.5.4 Drug Discovery
    • 4.5.5 Personalized Medicine
  • 4.6 Market Size & Forecast by Material Type (2020-2035)
    • 4.6.1 Blood Products
    • 4.6.2 Human Tissues
    • 4.6.3 Nucleic Acids
    • 4.6.4 Cell Lines
    • 4.6.5 Biological Fluids
  • 4.7 Market Size & Forecast by End User (2020-2035)
    • 4.7.1 Academic Institutions
    • 4.7.2 Pharmaceutical Companies
    • 4.7.3 Hospitals
    • 4.7.4 Research Laboratories
    • 4.7.5 Diagnostic Centers
  • 4.8 Market Size & Forecast by Process (2020-2035)
    • 4.8.1 Collection
    • 4.8.2 Preservation
    • 4.8.3 Distribution
    • 4.8.4 Quality Control
    • 4.8.5 Data Management
  • 4.9 Market Size & Forecast by Equipment (2020-2035)
    • 4.9.1 Refrigerators
    • 4.9.2 Freezers
    • 4.9.3 Automated Storage Systems
    • 4.9.4 Robotic Handling Systems
    • 4.9.5 Centrifuges
  • 4.10 Market Size & Forecast by Solutions (2020-2035)
    • 4.10.1 Biobanking Software
    • 4.10.2 Data Management Solutions
    • 4.10.3 Sample Tracking Solutions
    • 4.10.4 Inventory Management
    • 4.10.5 Compliance Solutions

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Application
      • 5.2.1.6 Material Type
      • 5.2.1.7 End User
      • 5.2.1.8 Process
      • 5.2.1.9 Equipment
      • 5.2.1.10 Solutions
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Application
      • 5.2.2.6 Material Type
      • 5.2.2.7 End User
      • 5.2.2.8 Process
      • 5.2.2.9 Equipment
      • 5.2.2.10 Solutions
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Application
      • 5.2.3.6 Material Type
      • 5.2.3.7 End User
      • 5.2.3.8 Process
      • 5.2.3.9 Equipment
      • 5.2.3.10 Solutions
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Application
      • 5.3.1.6 Material Type
      • 5.3.1.7 End User
      • 5.3.1.8 Process
      • 5.3.1.9 Equipment
      • 5.3.1.10 Solutions
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Application
      • 5.3.2.6 Material Type
      • 5.3.2.7 End User
      • 5.3.2.8 Process
      • 5.3.2.9 Equipment
      • 5.3.2.10 Solutions
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Application
      • 5.3.3.6 Material Type
      • 5.3.3.7 End User
      • 5.3.3.8 Process
      • 5.3.3.9 Equipment
      • 5.3.3.10 Solutions
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Application
      • 5.4.1.6 Material Type
      • 5.4.1.7 End User
      • 5.4.1.8 Process
      • 5.4.1.9 Equipment
      • 5.4.1.10 Solutions
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Application
      • 5.4.2.6 Material Type
      • 5.4.2.7 End User
      • 5.4.2.8 Process
      • 5.4.2.9 Equipment
      • 5.4.2.10 Solutions
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Application
      • 5.4.3.6 Material Type
      • 5.4.3.7 End User
      • 5.4.3.8 Process
      • 5.4.3.9 Equipment
      • 5.4.3.10 Solutions
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Application
      • 5.4.4.6 Material Type
      • 5.4.4.7 End User
      • 5.4.4.8 Process
      • 5.4.4.9 Equipment
      • 5.4.4.10 Solutions
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Application
      • 5.4.5.6 Material Type
      • 5.4.5.7 End User
      • 5.4.5.8 Process
      • 5.4.5.9 Equipment
      • 5.4.5.10 Solutions
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Application
      • 5.4.6.6 Material Type
      • 5.4.6.7 End User
      • 5.4.6.8 Process
      • 5.4.6.9 Equipment
      • 5.4.6.10 Solutions
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Application
      • 5.4.7.6 Material Type
      • 5.4.7.7 End User
      • 5.4.7.8 Process
      • 5.4.7.9 Equipment
      • 5.4.7.10 Solutions
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Application
      • 5.5.1.6 Material Type
      • 5.5.1.7 End User
      • 5.5.1.8 Process
      • 5.5.1.9 Equipment
      • 5.5.1.10 Solutions
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Application
      • 5.5.2.6 Material Type
      • 5.5.2.7 End User
      • 5.5.2.8 Process
      • 5.5.2.9 Equipment
      • 5.5.2.10 Solutions
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Application
      • 5.5.3.6 Material Type
      • 5.5.3.7 End User
      • 5.5.3.8 Process
      • 5.5.3.9 Equipment
      • 5.5.3.10 Solutions
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Application
      • 5.5.4.6 Material Type
      • 5.5.4.7 End User
      • 5.5.4.8 Process
      • 5.5.4.9 Equipment
      • 5.5.4.10 Solutions
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Application
      • 5.5.5.6 Material Type
      • 5.5.5.7 End User
      • 5.5.5.8 Process
      • 5.5.5.9 Equipment
      • 5.5.5.10 Solutions
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Application
      • 5.5.6.6 Material Type
      • 5.5.6.7 End User
      • 5.5.6.8 Process
      • 5.5.6.9 Equipment
      • 5.5.6.10 Solutions
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Application
      • 5.6.1.6 Material Type
      • 5.6.1.7 End User
      • 5.6.1.8 Process
      • 5.6.1.9 Equipment
      • 5.6.1.10 Solutions
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Application
      • 5.6.2.6 Material Type
      • 5.6.2.7 End User
      • 5.6.2.8 Process
      • 5.6.2.9 Equipment
      • 5.6.2.10 Solutions
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Application
      • 5.6.3.6 Material Type
      • 5.6.3.7 End User
      • 5.6.3.8 Process
      • 5.6.3.9 Equipment
      • 5.6.3.10 Solutions
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Application
      • 5.6.4.6 Material Type
      • 5.6.4.7 End User
      • 5.6.4.8 Process
      • 5.6.4.9 Equipment
      • 5.6.4.10 Solutions
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Application
      • 5.6.5.6 Material Type
      • 5.6.5.7 End User
      • 5.6.5.8 Process
      • 5.6.5.9 Equipment
      • 5.6.5.10 Solutions

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 BioCision
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Brooks Life Sciences
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Biostorage Technologies
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Cryoport
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Tecan Group
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 BioKryo
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Hamilton Company
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 BioLife Solutions
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 DNA Genotek
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Indivumed
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Provia Laboratories
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 RUCDR Infinite Biologics
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Zyagen
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 GenVault
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Cureline
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us